Title: High yield production and purification of recombinant staphylokinase for thrombolytic therapy
Authors: Schlott, B ×
Hartmann, M
Gührs, K H
Birch-Hirschfeid, E
Pohl, H D
Vanderschueren, Steven
Van de Werf, Frans
Michoel, Armand
Collen, Desire
Behnke, D #
Issue Date: 9-Mar-1994
Series Title: Bio/technology (Nature Publishing Company) vol:12 issue:2 pages:185-9
Abstract: Recombinant plasmids were constructed in which the signal sequence of the sak42D and the sakSTAR staphylokinase genes were replaced by an ATG start codon and which express staphylokinase under the control of a tac promoter and two Shine-Dalgarno sequences in tandem. Induction of transfected E. coli TGl cells in a bacterial fermentor produced intracellular staphylokinase representing 10 to 15% of total cell protein. Gram quantities of highly purified recombinant staphylokinase were obtained from cytosol fractions by chromatography, at room temperature, on SP-Sepharose and on phenyl-Sepharose columns, with yields of 50 to 70 percent. The material, at a dose of 4 mg/kg, did not produce acute reactions or affect body weight in mice. Intravenous administration of 10 mg SakSTAR over 30 minutes in five patients with acute myocardial infarction induced complete coronary artery recanalization, without associated fibrinogen degradation. However, neutralizing antibodies appeared in the plasma of all patients within 12 to 20 days. Thus, the present expression and purification method for recombinant staphylokinase yields large amounts of highly purified mature protein (approximately 200 mg per liter fermentation broth) suitable for a more detailed clinical investigation of its potential as a thrombolytic agent.
ISSN: 0733-222X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Cardiology
Molecular and Vascular Biology
Laboratory for Clinical Infectious and Inflammatory Disorders
Drug Delivery and Disposition
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
1994 - Schlott - High yield production and purification of recombinant staphylokinase for thrombolytic therapy - Bio-technol.pdf Published 754KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science